[Antithrombin III and congenital hemolytic anemia].
Giustolisi
R
R
Cattedra di Ematologia, Università di Catania.
Musso
R
R
Cacciola
E
E
D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000990:Antithrombin III / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000032:analysis; D004341:Drug Evaluation; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D012805:Sickle Cell Trait / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013789:Thalassemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology
D001798:Blood Proteins; D000990:Antithrombin III; D006493:Heparin
Antitrombina III ed anemie emolitiche congenite.